Tag: fda

Stress Checks
Breakthrough pancreatic cancer drug doubles survival in late-stage patients
FDA-approved daraxonrasib may double survival for late-stage pancreatic cancer patients after chemotherapy failure, per University of Chicago trial data.

Stress Checks
FDA approves Mounjaro for diabetes heart risk reduction
FDA approves Mounjaro for diabetes to reduce heart risks in adults. This new approval lowers risks of major adverse cardiovascular…

Drug Doses
FDA clears new drug for rare skin condition
The FDA approved Lisraya (brepocitinib) for dermatomyositis, a rare skin condition causing inflammation and muscle weakness, offering targeted treatment.

Diet Links
FDA approves new drug for rare bone disease
The FDA approves Pasatru, a breakthrough drug for fibrodysplasia ossificans progressiva (FOP), a rare bone disease affecting 900 people worldwide.
